What factors affect DHEA dosing?

DHEA, a commonly used abbreviation for the hormonal precursor dehydroepiandosterone, is popular, albeit controversial, supplement in pharmacopeia alternative medicine. While Androstenooone has been removed from the market by the United States of Food and Drug Administration, since 2011, DHEA has remained available in North America. No longitudinal studies have been published that could be used to determine a safe or effective DHEA dosing level in any population, and the views of experts differ very much on this topic, and the DHEA dosing recommendations differ from irregular episodic use of 5 mg per day to daily oral doses greater than 1000 mg. If there is no sufficient clinical or experimental evidence that has informed judgment, factors that are most likely determined by the recommendations of DHEA dosing, the philosophical orientation of the doctor recommending hormone and its belief in safety.

Ray Sahelian, M.D. is one of the most conservativeMore ativative alternative doctors in his approach to using DHEA. Due to concerns about the long -term safety of any preliminary hormone, Dr. Sahelian advocates strongly against the use of DHEA if alternative approaches to treatment have no longer failed. It recommends that patients with demonstrably low DHEA levels who do not respond to other treatment and want to try a supplement, start with a single 5 mg dose of DHEA, alternating on alternative days or no more than five days a week. Very few commercially available DHEA accessories are available at 5 mg doses.

Baylor College of Medicine recommends that the initial dose of DHEA be used in geriatric patients at most 25 mg, which is much lower than the dose most often to the laying of Ble DHEA. DHEA levels in serum should then be monitored to see if optimal DHEA levels have been achieved. These recommendations are based on the facts thatE before the decline in DHEA production related to age, a healthy man produces 25 mg pre -hormone and a healthy woman produces 17 mg daily. Since geriatric patients still produce a significant amount of DHEA, these doses can also be considered high.

While many concerns about dosing DHEA have been based on unofficial reports on side effects, it is important to take into account that several clinical placebo studies at doses up to 100 mg daily for six months to a year to a year to a statistically significant incidence of any side effects. However, concerns about the use of any drug that can increase serum sex hormones may be valid. Sufficient evidence suggests that the increased levels of certain sex hormones can correlate with the growth of the anesthesia of various cancer. An alternative alternative 7-Keto® DHEA has been released on the market in an attempt to reduce the potential of cancer risk. Unfortunately there are insufficient evidence that suggests that 7-keThis has less influence on the production of sex hormones than DHEA.